Alpha Orthotics announces launch of its Medial Mid-foot Brace in the U.S.

NewsGuard 100/100 Score

Splayfoot, also called "fallen arch" occurs when the arch of the foot collapses, with the entire sole of the foot coming into complete or near-complete contact with the ground. An estimated 20%-30% of Americans have this condition where the arch never develops, or collapses in one or both feet.

Alpha Orthotics Corporation (www.alphaorthotics.com) announced today the launch of its Medial Mid-foot Brace in the United States. The Medial Mid-foot Brace provides longitudinal arch support, relieving mid-foot pain caused by general foot stress and strain including splayfoot and fallen arch. One size fits all, the same device can be worn on either the right or left foot and the brace is thin enough to slip into non-restrictive dress or casual shoes. The Medial Mid-foot Brace launched into Europe in early 2009 and is available online through the Alpha Orthotics website (www.alphaorthotics.com) and through select retailers and podiatrists nationwide at a suggested retail price of $49.95.

"Fallen Arch is a very common problem which can cause tremendous pain," stated Gaby Federal, President of Alpha Orthotics Corporation. "Our Medial Mid-foot Brace is a simple and effective pain relief device people can use while engaging in sports activity such as running, tennis and golf, and for people who need to be on their feet and active for work."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research demonstrates a bat species' resistance to cancer, pinpoints key genes